Anti‐thymocyte globulin and post‐transplant cyclophosphamide predisposes to inferior outcome when using cryopreserved stem cell grafts

During 2020, the concurrent novel COVID‐19 pandemic lead to widespread cryopreservation of allogeneic hematopoietic cell transplant grafts based on National Marrow Donor Program and European Society of Blood and Marrow Transplantation recommendations, in order to secure grafts before the start of co...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	EUROPEAN JOURNAL OF HAEMATOLOGY 2022-01, Vol.108 (1), p.61-72
Hauptverfasser:	Novitzky‐Basso, Igor, Remberger, Mats, Chen, Carol, Pasić, Ivan, Lam, Wilson, Law, Arjun, Gerbitz, Armin, Viswabandya, Auro, Lipton, Jeffrey H., Kim, Dennis D., Kumar, Rajat, Mattsson, Jonas, Michelis, Fotios V.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult Aged allogeneic stem cell transplant Antilymphocyte Serum - therapeutic use Chemotherapy COVID-19 COVID-19 - epidemiology Cryopreservation Cryopreservation - methods Cyclophosphamide Cyclophosphamide - therapeutic use Female Globulins Graft rejection Graft vs Host Disease Graft-versus-host reaction Grafts Hematopoietic Stem Cell Transplantation - methods Hematopoietic stem cells Hematopoietic Stem Cells - cytology Humans Immunologi Immunological tolerance Immunology Leukemia, Myeloid, Acute - therapy Leukocytes (neutrophilic) Male Medical Science Medicinsk vetenskap Middle Aged Pandemics Peripheral blood Recurrence Retrospective Studies Stem cell transplantation Stem cells Transplantation Conditioning Transplants & implants Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!